Single‐cell mass cytometry adapted to measurements of the cell cycle
Tóm tắt
Mass cytometry is a recently introduced technology that utilizes transition element isotope‐tagged antibodies for protein detection on a single‐cell basis. By circumventing the limitations of emission spectral overlap associated with fluorochromes utilized in traditional flow cytometry, mass cytometry currently allows measurement of up to 40 parameters per cell. Recently, a comprehensive mass cytometry analysis was described for the hematopoietic differentiation program in human bone marrow from a healthy donor. The current study describes approaches to delineate cell cycle stages utilizing 5‐iodo‐2‐deoxyuridine (IdU) to mark cells in S phase, simultaneously with antibodies against cyclin B1, cyclin A, and phosphorylated histone H3 (S28) that characterize the other cell cycle phases. Protocols were developed in which an antibody against phosphorylated retinoblastoma protein (Rb) at serines 807 and 811 was used to separate cells in G0 and G1 phases of the cell cycle. This mass cytometry method yielded cell cycle distributions of both normal and cancer cell populations that were equivalent to those obtained by traditional fluorescence cytometry techniques. We applied this to map the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage. © 2012 International Society for Advancement of Cytometry
Từ khóa
Tài liệu tham khảo
Griffin J, 1986, Clonogenic cells in acute myeloblastic leukemia, Blood, 68, 1185–1195, 10.1182/blood.V68.6.1185.1185
Moore MA, 1974, Agar culture studies in 127 cases of untreated acute leukemia: The prognostic value of reclassification of leukemia according to in vitro growth characteristics, Blood, 44, 1–18, 10.1182/blood.V44.1.1.1
Raza A, 1997, Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo‐ and/or bromodeoxyuridine, Exp Hematol, 25, 530
Pearce DJ, 2006, AML engraftment in the NOD/SCID assay reflects the outcome of AML: Implications for our understanding of the heterogeneity of AML, Blood, 107, 1166–1173, 10.1182/blood-2005-06-2325
van Lochem EG, 2004, Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age‐related changes and disease‐induced shifts, Cytometry Part B: Clinical Cytometry, 60, 1–13
2011, Asymmetric cancer cell division regulated by AKT, Proc Natl Acad Sci, 108, 12845–12850
Gong J, 1994, Unscheduled expression of Cyclin B1 and Cyclin E in several leukemic and solid tumor cell lines, Cancer Res, 54, 4285–4288
Passegue E, 2005, Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates, J Exp Med, 202, 1599–1611, 10.1084/jem.20050967
Head DR, 2011, Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis, Bone Marrow Res, 2011